MYLAN FDA Approval ANDA 211431

ANDA 211431

MYLAN

FDA Drug Application

Application #211431

Application Sponsors

ANDA 211431MYLAN

Marketing Status

Prescription001

Application Products

001TABLET, EXTENDED RELEASE;ORAL330MG0PREGABALINPREGABALIN

FDA Submissions

UNKNOWN; ORIG1AP2021-07-02STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

MYLAN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211431
            [companyName] => MYLAN
            [docInserts] => ["",""]
            [products] => [{"drugName":"PREGABALIN","activeIngredients":"PREGABALIN","strength":"330MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/02\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-07-02
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.